Subtotal $0.00
Swiss Health Clinic AG
Stauffacherstr. 36
CH-8200 Schaffhausen
- Phone:+41 (52) 56030-00
- Email:info@swiss-health-clinic.ch
Swiss Health Clinic AG
Stauffacherstr. 36
CH-8200 Schaffhausen
In the vast landscape of medical treatments, hyperthermia stands out as a fascinating yet effective therapeutic approach. Often misunderstood or overlooked, hyperthermia offers a unique avenue for addressing various health conditions. Derived from the Greek word meaning “warming,” hyperthermia involves raising the temperature of targeted body regions for therapeutic purposes.
Extracorporeal Hemoperfusion (EHP®) is a cutting-edge therapeutic intervention that combines Hemo-hyperthermia, Hemoperfusion and Oxygenation techniques. This innovative approach is designed to specifically target and eliminate a spectrum of harmful substances, including toxins, inflammatory markers, cancer cells, pathogens, and more.
As the name suggests, this type involves raising the body's core temperature systematically. It's a more intensive procedure conducted in a controlled medical setting and is utilized in treating conditions like systemic infections or certain cancers.
This method involves heating a specific area of the body, typically using techniques like microwave, radiofrequency, or ultrasound. It's commonly used in treating tumors or deep-seated infections.
In this approach, larger areas of the body are heated, such as an entire limb or organ. Techniques may include heating pads or warm water blankets. Regional hyperthermia is often employed alongside other treatments like chemotherapy or radiation therapy.
Cancer cells demonstrate increased sensitivity to heat compared to healthy cells. Elevating the temperature of cancerous sites, typically between 40°C to 44°C, triggers the production of heat shock proteins within tumors. These proteins serve as signals for the immune system, activating killer cells that specifically target and attack the cancerous tissue. Additionally, hyperthermia increases blood flow through tumor tissue, enhancing its responsiveness to medications or radiation. Administered alongside chemotherapy and/or radiation therapy, hyperthermia reduces the required dosage of cytostatic drugs, diminishes the repair capacity of damaged tumor cells, and augments the efficacy of radiation therapy.
Hyperthermia improves the effectiveness of conventional cancer treatments, leading to better therapeutic outcomes.
Incorporating hyperthermia into cancer therapy results in a notable reduction in side effects, including hair loss, nausea, and associated physical and mental stresses.
Tumors that had developed resistance to chemotherapy or radiation therapy exhibit responsiveness to these treatments again after hyperthermia.
Hyperthermia has shown promise in alleviating chronic pain conditions by promoting muscle relaxation and improving blood flow to affected areas.
Hyperthermia finds application in a diverse range of medical scenarios, including but not limited to
It is often utilized as an adjuvant therapy alongside conventional cancer treatments like chemotherapy and radiation therapy to enhance their efficacy and reduce tumor burden.
Hyperthermia plays a crucial role in treatment of patients suffering from persistent viral or bacterial infections like Long-COVID-Syndrome and Lyme disease by augmenting the body’s immune response and aiding in pathogen clearance.
Conditions characterized by dysregulated immune function, such as lupus and Crohn’s disease, may benefit from the immune-modulating effects of hyperthermia.
Individuals suffering from chronic pain conditions, including neuropathic pain and musculoskeletal disorders, may experience relief through the analgesic properties of whole-body hyperthermia.